The p53high/DSS1high group showed a worse prognosis in comparison with the p53low/DSS1high group in breast cancer cases (Figure 1B), suggesting that the increased p53 status accelerates the effect of DSS1 over-expression on tumor progression under regular clinical treatments. This evidence concerns the gene TP53 and breast carcinoma.